Viewing Study NCT07215832


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2025-12-25 @ 7:35 PM
Study NCT ID: NCT07215832
Status: AVAILABLE
Last Update Posted: 2025-10-14
First Post: 2025-09-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Karyopharm Expanded Access Program for Selinexor
Sponsor: Karyopharm Therapeutics Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module